参考文献/References:
[1]Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet,2022,399(10333):1412-1428.
[2]Arend RC, Jones BA, Martinez A, et al. Endometrial cancer: Molecular markers and management of advanced stage disease. Gynecol Oncol,2018,150(3):569-580.
[3]Hutt S, Tailor A, Ellis P, et al. The role of biomarkers in endometrial cancer and hyperplasia: a literature review.Acta Oncol,2019,58(3):342-352.
[4]王露露,吕巧英,罗雪珍.子宫内膜癌保育治疗孕激素耐药分子机制的相关研究进展.复旦学报(医学版),2021,48(3):410-417.
[5]Sykaras AG, Christofidis K, Politi E, et al. Exosomes on endometrial cancer: A biomarkers treasure trove? Cancers (Basel), 2022,14(7):1733.
[6]Cordonnier M, Chanteloup G, Isambert N, et al. Exosomes in cancer theranostic: Diamonds in the rough. Cell Adh Migr,2017,11(2):151-163.
[7]罗艳露,范江涛.外泌体调控妇科恶性肿瘤相关机制的研究进展.医学综述,2021,27(15):2982-2987.
[8]Han QF, Li WJ, Hu KS, et al. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer,2022,21(1):207.
[9]MuineloRomay L, CasasArozamena C, Abal M. Liquid biopsy in endometrial cancer: New opportunities for personalized oncology. Int J Mol Sci,2018,19(8):2311.
[10]Miao M, Miao Y, Zhu Y, et al. Advances in exosomes as diagnostic and therapeutic biomarkers for gynaecological malignancies. Cancers (Basel),2022,14(19):4743.
[11]Fan X, Zou X, Liu C, et al. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer. Biosci Rep,2021,41(6):BSR20210111.
[12]Jurmeister S, Baumann M, Balwierz A, et al. MicroRNA200c represses migration and invasion of breast cancer cells by targeting actinregulatory proteins FHOD1 and PPM1F. Mol Cell Biol,2012,32(3):633-651.
[13]Pan Y, Liang H, Chen W, et al. microRNA200b and microRNA200c promote colorectal cancer cell proliferation via targeting the reversioninducing cysteinerich protein with Kazal motifs. RNA Biol,2015,12(3):276-289.
[14]Zhou L, Wang W, Wang F, et al. Plasmaderived exosomal miR15a5p as a promising diagnostic biomarker for early detection of endometrial carcinoma. Mol Cancer,2021,20(1):57.
[15]Srivastava A, Moxley K, Ruskin R, et al. A noninvasive liquid biopsy screening of urinederived exosomes for miRNAs as biomarkers in endometrial cancer patients. Aaps J,2018,20(5):82.
[16]Che X, Jian F, Chen C, et al. PCOS serumderived exosomal miR27a5p stimulates endometrial cancer cells migration and invasion. J Mol Endocrinol,2020,64(1):1-12.
[17]Wang J, Gong X, Yang L, et al. Loss of exosomal miR26a5p contributes to endometrial cancer lymphangiogenesis and lymphatic metastasis. Clin Transl Med,2022,12(5):e846.
[18]Zheng W, Yang J, Wang Y, et al. Exosomal miRNA93 and miRNA205 expression in endometrial cancer. J King Saud Univ Sci,2020,32(1):1111-1115.
[19]Song Y, Wang M, Tong H, et al. Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression. Oncogene,2021,40(3):633-646.
[20]邢义高,张君,田振辉,等.比较两种方法提取人脐带间充质干细胞外泌体的效果.江苏医药,2023,49(1):5-8.
[21]Zhou WJ, Zhang J, Xie F, et al. CD45RO-CD8+ T cellderived exosomes restrict estrogendriven endometrial cancer development via the ERβ/miR765/PLP2/Notch axis. Theranostics,2021,11(11):5330-5345.
[22]Xiao L, He Y, Peng F, et al. Endometrial cancer cells promote M2like macrophage polarization by delivering exosomal miRNA21 under hypoxia condition. J Immunol Res,2020,2020:9731049.
[23]Sun Z, Yang S, Zhou Q, et al. Emerging role of exosomederived long noncoding RNAs in tumor microenvironment. Mol Cancer,2018,17(1):82.
[24]Li BL, Lu W, Qu JJ, et al. Loss of exosomal miR148b from cancerassociated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis. J Cell Physiol,2019,234(3):2943-2953.
[25]Jing L, Hua X, Yuanna D, et al. Exosomal miR499a5p inhibits endometrial cancer growth and metastasis via targeting VAV3. Cancer Manag Res,2020,12:13541-13552.
[26]Gu X, Shi Y, Dong M, et al. Exosomal transfer of tumorassociated macrophagederived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer. Cell Death Dis,2021,12(9):818.
[27]Jia Y, Liu M, Wang S. CircRNA hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis in endometrial cancer via downregulating LRIG2 by sponging miR182. Cancer Cell Int, 2020,20:412.
[28]Shi R, Zhang W, Zhang J, et al. CircESRP1 enhances metastasis and epithelialmesenchymal transition in endometrial cancer via the miR8743p/CPEB4 axis. J Transl Med,2022, 20(1):139.
[29]Wei D, Tian M, Fan W, et al. Circular RNA circ_0000043 promotes endometrial carcinoma progression by regulating miR12715p/CTNND1 axis. Arch Gynecol Obstet,2021,303(4):1075-1087.
[30]Chen Z, Huang M, You J, et al. Circular RNA hsa_circ_0023404 promotes the proliferation, migration and invasion in endometrial cancer cells through regulating miR217/MAPK1 axis. Eur J Med Res,2022,27(1):242.
[31]Fan JT, Zhou ZY, Luo YL, et al. Exosomal lncRNA NEAT1 from cancerassociated fibroblasts facilitates endometrial cancer progression via miR26a/b5pmediated STAT3/YKL40 signaling pathway. Neoplasia,2021,23(7):692-703.
[32]Jia J, Guo S, Zhang D, et al. ExosomallncRNA DLEU1 accelerates the proliferation, migration, and invasion of endometrial carcinoma cells by regulating microRNAE2F3. Onco Targets Ther,2020,13:8651-8663.
[33]Song Y, Ye L, Tan Y, et al. Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin beta1/FAK signaling pathway. Cell Oncol (Dordr),2022,45(5):861-872.
[34]Li MY, Liu LZ, Dong M. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol Cancer,2021,20(1):22.
[35]Ye M, Wang J, Pan S, et al. Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. Mol Ther Oncolytics,2022,24:101-113.